Current Report Filing (8-k)
February 27 2015 - 6:14AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
February 24, 2015
FV PHARMA INTERNATIONAL CORP.
(Exact name of registrant as specified in its
charter)
Nevada |
333-187669 |
68-0682594 |
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
203 – 29 Gervais Drive
Toronto, Ontario, Canada M3C 1Y9
(Address of principal executive offices)
(416) 444-4427
(Registrant’s telephone number, including
area code)
N/A
(Former name, former address and former fiscal
year, if changed since last report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 4.02 Non-Reliance
on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
On February 18, 2015, FV Pharma International
Corp. (the “Company”) filed two quarterly reports on Form 10-Q for the periods ended July 31, 2014 and October 31,
2014 (the “Quarterly Reports”) with the Securities and Exchange Commission (the “SEC”). These filings were
completed without the consent of the Company’s independent registered public accounting firm, Cutler & Co., LLC (the
“Auditors”), as the Company did not request the Auditors to undertake a review of the interim financial statements
included in the Quarterly Reports using professional standards and procedures conducted for such reviews as established by generally
accepted auditing standards. The Company’s sole officer and director and the Auditors have therefore determined that the
financial statements included in the Quarterly Reports should not be relied upon.
The Auditors notified the Company on February
24, 2015 that action should be taken to prevent future reliance on the interim financial statements included in the Quarterly Reports
and requested that the Quarterly Reports be amended; the Company is currently planning to do so with proper
authorization from the Auditors.
The Company has provided the Auditors with
a copy of this Form 8-K and has requested that the Auditors furnish the Company with a letter addressed to the SEC stating whether
the Auditors agree with statements contained herein and, if not, stating the respects in which they do not agree. A copy of this
letter is included as Exhibit 16.1 hereto.
Exhibit
Number |
|
Exhibit Description |
16.1 |
|
Letter from Cutler & Co., LLC dated February 26, 2015 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 26, 2015 |
FV Pharma International Corp. |
|
|
|
|
By: |
/s/ Shaikh M. Shami |
|
|
Shaikh M. Shami |
|
|
President, Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Secretary, Treasurer, Director |
EXHIBIT
16.1
February 26, 2014
Office of the Chief Accountant
Securities and Exchange Commission
460 Fifth Street N. W.
Washington, DC 20549
| RE: | FV PHARMA INTERNATIONAL CORP. |
COMMISSION
FILE NUMBER 333-187669
Dear Sirs:
We are in agreement
with the statements we understand are being made by FV Pharma International Corp. in its Form 8-K dated February 26, 2014.
We hereby consent
to the filing of this letter as an exhibit to the foregoing report on Form 8-K.
Sincerely,
Cutler & Co. LLC
9605 West 49th Ave. Suite 200 Wheat Ridge, Colorado
80033 ~ Phone 303-968-3281 ~ Fax 303-456-7488 ~ www.cutlercpas.com